NCT05561387 | S2209 | SWOG | Green Bay Oncology

Clinical Trial: NCT05561387 | S2209 | SWOG

NCT Number: NCT05561387

Protocol ID: S2209

Sponsor: SWOG

Disease Site: Multiple Myeloma

Disease Category: Multiple Myeloma

Detail: A Phase III Randomized Trial For Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail Or in a Subset of â€œIntermediate Fitâ€ Comparing Upfront Three-Drug Induction Regimens Followed by Double- or Single-Agent Maintenance

For more details, click here.

Interested in participating in this trial?

Clinical Trial

First Name

Last Name

Phone

Preferred Contact Method:

Preferred Location:

Patient Type:

Current Patient New Patient

Interested in:

Cancer Clinical Trial Blood Disorder Clinical Trial

Disease Site:

Disease Category

What do all the numbers mean on clinical trials?

National Clinical Trial Identifier

The National Clinical Trial (NTC) is assigned by the National Library of Medicine when a new study appears in the clinical trials database.

ex: NCT0526225 | GY026 | NRG

PROTOCOL IDENTIFICATION NUMBER

Any unique identifier assigned to the protocol by the sponsor.

ex: NCT0526225 | GY026 | NRG

STUDY SPONSOR

A sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage and/or finance the clinical trial.

ex: NCT0526225 | GY026 | NRG